首页> 外国专利> Isolated myeloid-like bone marrow cell populations and methods of treatment therewith

Isolated myeloid-like bone marrow cell populations and methods of treatment therewith

机译:分离的骨髓样骨髓细胞群及其治疗方法

摘要

The present invention provides an isolated myeloid-like cell population comprising a majority of cells that are lineage negative, and which express both CD44 antigen, CD11b antigen, and hypoxia inducible factor 1 α (HIF-1 α). These cells have beneficial vasculotrophic and neurotrophic activity when intraocularly administered to the eye of a mammal, particularly a mammal suffering from an ocular degenerative disease. The myeloid-like cells are isolated by treating bone marrow cells, peripheral blood cells or umbilical cord cells with an antibody against CD44 (hyaluronic acid receptor), against CD11b, CD14, CD33, or against a combination thereof and using flow cytometry to positively select CD44 and/or CD11b expressing cells therefrom. The isolated myeloid-like bone marrow cells of the invention can be transfected with a gene encoding a therapeutically useful protein, for delivering the gene to the retina.
机译:本发明提供了一种分离的骨髓样细胞群,其包含大多数细胞系阴性,并且表达CD44抗原,CD11b抗原和缺氧诱导因子1α(HIF-1α)。当眼内施用给哺乳动物,特别是患有眼退化性疾病的哺乳动物的眼睛时,这些细胞具有有益的血管营养和神经营养活性。通过用抗CD44(透明质酸受体),抗CD11b,CD14,CD33或它们的组合的抗体处理骨髓细胞,外周血细胞或脐带细胞并使用流式细胞仪阳性选择来分离骨髓样细胞从中表达CD44和/或CD11b的细胞。可以用编码治疗上有用的蛋白质的基因转染本发明的分离的髓样骨髓细胞,以将该基因递送至视网膜。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号